Cargando…
Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits
There is increasing evidence that many GWAS risk loci are molecular QTL (eQTL, hQTL, sQTL, and/or meQTL). Here, we introduce a new set of functional annotations based on causal posterior probabilities of fine-mapped molecular cis-QTL, using data from the GTEx and BLUEPRINT consortia. We show that th...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030458/ https://www.ncbi.nlm.nih.gov/pubmed/29942083 http://dx.doi.org/10.1038/s41588-018-0148-2 |
_version_ | 1783337151913525248 |
---|---|
author | Hormozdiari, Farhad Gazal, Steven van de Geijn, Bryce Finucane, Hilary Ju, Chelsea J.-T. Loh, Po-Ru Schoech, Armin Reshef, Yakir Liu, Xuanyao O’Connor, Luke Gusev, Alexander Eskin, Eleazar Price, Alkes L. |
author_facet | Hormozdiari, Farhad Gazal, Steven van de Geijn, Bryce Finucane, Hilary Ju, Chelsea J.-T. Loh, Po-Ru Schoech, Armin Reshef, Yakir Liu, Xuanyao O’Connor, Luke Gusev, Alexander Eskin, Eleazar Price, Alkes L. |
author_sort | Hormozdiari, Farhad |
collection | PubMed |
description | There is increasing evidence that many GWAS risk loci are molecular QTL (eQTL, hQTL, sQTL, and/or meQTL). Here, we introduce a new set of functional annotations based on causal posterior probabilities of fine-mapped molecular cis-QTL, using data from the GTEx and BLUEPRINT consortia. We show that these annotations are far more strongly enriched for heritability (e.g. 5.84x for eQTL; P=1.19×10(−31)) across 41 independent diseases and complex traits than annotations containing all significant molecular QTL (1.80x for eQTL). eQTL annotations that were obtained by meta-analyzing all GTEx tissues generally performed best, but tissue-specific eQTL annotations produced stronger enrichments for blood- and brain-related diseases and traits. Notably, eQTL annotations restricted to loss-of-function intolerant genes from ExAC were even more strongly enriched for heritability (17.06x; P=1.20×10(−35)). All molecular QTL except sQTL remained significantly enriched in a joint analysis, implying that each of these annotations is uniquely informative for disease and complex trait architectures. |
format | Online Article Text |
id | pubmed-6030458 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
record_format | MEDLINE/PubMed |
spelling | pubmed-60304582018-12-25 Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits Hormozdiari, Farhad Gazal, Steven van de Geijn, Bryce Finucane, Hilary Ju, Chelsea J.-T. Loh, Po-Ru Schoech, Armin Reshef, Yakir Liu, Xuanyao O’Connor, Luke Gusev, Alexander Eskin, Eleazar Price, Alkes L. Nat Genet Article There is increasing evidence that many GWAS risk loci are molecular QTL (eQTL, hQTL, sQTL, and/or meQTL). Here, we introduce a new set of functional annotations based on causal posterior probabilities of fine-mapped molecular cis-QTL, using data from the GTEx and BLUEPRINT consortia. We show that these annotations are far more strongly enriched for heritability (e.g. 5.84x for eQTL; P=1.19×10(−31)) across 41 independent diseases and complex traits than annotations containing all significant molecular QTL (1.80x for eQTL). eQTL annotations that were obtained by meta-analyzing all GTEx tissues generally performed best, but tissue-specific eQTL annotations produced stronger enrichments for blood- and brain-related diseases and traits. Notably, eQTL annotations restricted to loss-of-function intolerant genes from ExAC were even more strongly enriched for heritability (17.06x; P=1.20×10(−35)). All molecular QTL except sQTL remained significantly enriched in a joint analysis, implying that each of these annotations is uniquely informative for disease and complex trait architectures. 2018-06-25 2018-07 /pmc/articles/PMC6030458/ /pubmed/29942083 http://dx.doi.org/10.1038/s41588-018-0148-2 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Hormozdiari, Farhad Gazal, Steven van de Geijn, Bryce Finucane, Hilary Ju, Chelsea J.-T. Loh, Po-Ru Schoech, Armin Reshef, Yakir Liu, Xuanyao O’Connor, Luke Gusev, Alexander Eskin, Eleazar Price, Alkes L. Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits |
title | Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits |
title_full | Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits |
title_fullStr | Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits |
title_full_unstemmed | Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits |
title_short | Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits |
title_sort | leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030458/ https://www.ncbi.nlm.nih.gov/pubmed/29942083 http://dx.doi.org/10.1038/s41588-018-0148-2 |
work_keys_str_mv | AT hormozdiarifarhad leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits AT gazalsteven leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits AT vandegeijnbryce leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits AT finucanehilary leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits AT juchelseajt leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits AT lohporu leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits AT schoecharmin leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits AT reshefyakir leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits AT liuxuanyao leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits AT oconnorluke leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits AT gusevalexander leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits AT eskineleazar leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits AT pricealkesl leveragingmolecularquantitativetraitlocitounderstandthegeneticarchitectureofdiseasesandcomplextraits |